» Articles » PMID: 17392750

Cancer Patients Opt for Unapproved Drug

Overview
Journal Nature
Specialty Science
Date 2007 Mar 30
PMID 17392750
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

All-in-One Pyruvate Dehydrogenase Kinase Inhibitor for Tracking, Targeting, and Enhanced Efficacy.

Zhang X, Sarkar S, Ashokan A, Surnar B, Kolishetti N, Dhar S Bioconjug Chem. 2023; 34(6):1122-1129.

PMID: 37279374 PMC: 10903362. DOI: 10.1021/acs.bioconjchem.3c00152.


A potent tumoricidal co-drug 'Bet-CA'--an ester derivative of betulinic acid and dichloroacetate selectively and synergistically kills cancer cells.

Saha S, Ghosh M, Dutta S Sci Rep. 2015; 5:7762.

PMID: 25585916 PMC: 4293591. DOI: 10.1038/srep07762.


Pyruvate dehydrogenase kinase as a potential therapeutic target for malignant gliomas.

Jha M, Suk K Brain Tumor Res Treat. 2014; 1(2):57-63.

PMID: 24904893 PMC: 4027103. DOI: 10.14791/btrt.2013.1.2.57.


Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate.

Pathak R, Marrache S, Harn D, Dhar S ACS Chem Biol. 2014; 9(5):1178-87.

PMID: 24617941 PMC: 4033660. DOI: 10.1021/cb400944y.


Two mixed-NH3/amine platinum (II) anticancer complexes featuring a dichloroacetate moiety in the leaving group.

Liu W, Su J, Jiang J, Li X, Ye Q, Zhou H Sci Rep. 2013; 3:2464.

PMID: 23955304 PMC: 3746205. DOI: 10.1038/srep02464.